mVASC® Protection Status

mVASC® is a processed human microvascular tissue allograft containing structural tissue fragments, associated nonviable cells, and inherent biological factors that enhance healing potential by increasing blood supply and providing the foundation for tissue repair.

Microvascular Tissues, Inc. (MVT) is an evidence-based regenerative medicine company developing and commercializing products that address vascular deficiencies using vascular solutions, including mVASC®, an allogeneic structural microvascular tissue graft.

(858) 522-0633

Important Notice: The contents of the website such as text, graphics, images, and other materials contained on the website ("Content") are for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. The content is not intended to substitute manufacturer instructions. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or product usage. Refer to the Legal Notice for express terms of use.